These medications also slow gastric emptying, creating a feeling of fullness and supporting weight management, which is essential for many diabetes patients
Research enrollment : If possible, enrolling in clinical trials designed to test GLP-1 RAs for dementia prevention or early AD may help (and give access to more intensive monitoring)
FDA GLP-1 approval to reduce cardiovascular risk in obesity World Health Organization 2025 guideline on GLP-1 medicines for obesity NIH / PubMed cardiovascular and kidney outcomes of GLP-1 in older adults The Lancet eClinicalMedicine GLP-1 use and lower dementia risk in older adults The BMJ gastrointestinal side effects of GLP-1 medications The Lancet Healthy Longevity GLP-1 and sarcopenia risk in frail older adults NIH / PubMed dehydration and GLP-1 therapy ScienceDirect long-term safety considerations for GLP-1 use ScienceDirect monitoring guidance for GLP-1 medications MDWatch Weight-Loss Program See if a GLP-1 is right for you Get a personalized plan from board-certified medical providers who treat seniors every day

Potential additional indications being studied: Type 2 diabetes management Metabolic dysfunction-associated steatotic liver disease (MASLD, formerly called NAFLD) Knee osteoarthritis Obstructive sleep apnea Cardiovascular and renal outcomes in obesity How do you get retatrutide right now
HCAR2: hydroxycarboxylic acid receptor 2
This tailored approach can increase the chances of successful weight loss